Photograph of the implant prostheses with different hole opening strategies. by Long Li (6555)

Effect of the addition of ZrO₂ on DTS of the perovskite structure. by Md. Abu Daud (21485629)

Distribution of cases and adverse events associated with metformin. by Mengsi Peng (12882734)

Age-Period-Cohort Model Analysis of Gastric Cancer Incidence and Mortality in Taiwan. by Xiaohuang Yang (10182727)

Trends of age-specific burden of gastric cancer in Taiwan by gender from 1990 to 2021. by Xiaohuang Yang (10182727)

Chromatogram results of quantitative and qualitative analysis the PLE. by Xiaoqiang Huang (1457860)

Daily behavior of three variables during cocoa fermentation in three processing plants in the department of Caquetá. by Andrés Felipe Ramírez González (19797070)

Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

Jadad Score of randomized controlled trials. by Solima Sabeel (9545738)

The weight percentage of ZrO₂ and MnO₂ in the fabricated composite. by Md. Abu Daud (21485629)

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

The comparisons of key properties for different ZrO₂-doped fabricated composites. by Md. Abu Daud (21485629)

Front and side images of the computer-aided design of the prostheses, including an interior perspective showing the location and size of the holes. by Long Li (6555)

Excluded skewed studies. by Solima Sabeel (9545738)

Summary of randomized controlled trials. by Solima Sabeel (9545738)

Summary of non-randomized studies. by Solima Sabeel (9545738)

Projections of Gastric Cancer Incidence and Mortality Burden in Taiwan Through 2036. by Xiaohuang Yang (10182727)

Related to Fig 1. by Mohammad Nafees Ansari (22232505)

“…(<b>E</b>–<b>H</b>) Absolute quantification (mean ± SEM, <i>n</i> = 3–4) of GM3 (E), GD3 (F), GM2 (G), and GM1 (H) gangliosides shows an increase in GD3 and GM2 gangliosides and a decrease in GM3 and GM1 gangliosides in BT-474_UGCG^OE cells compared to BT-474 cells. …”